Measuring bleeding as an outcome in clinical trials of prophylactic platelet transfusions

被引：13
|
作者：
Bercovitz, Rachel S. [1 ]
O'Brien, Sarah H. [2 ,3 ]
机构：
[1] Childrens Hosp Colorado, Aurora, CO USA
[2] Nationwide Childrens Hosp, Res Inst, Ctr Innovat Pediat Practice, Columbus, OH USA
[3] Ohio State Univ, Nationwide Childrens Hosp, Div Pediat Hematol Oncol, Columbus, OH 43210 USA
来源：
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM | 2012年
关键词：
PROSPECTIVE RANDOMIZED-TRIAL; PROGENITOR-CELL TRANSPLANT; ACUTE-LEUKEMIA; THROMBOCYTOPENIA; RECIPIENTS; THRESHOLD; THERAPY;
D O I：
10.1182/asheducation-2012.1.157
中图分类号：
G40 [教育学];
学科分类号：
040101 ; 120403 ;
摘要：
A 12-year-old girl with acute myeloid leukemia has completed her third cycle of chemotherapy and is in the hospital awaiting count recovery. Her platelet count today is 15 000 and, based on your institution's protocol, she should receive a prophylactic platelet transfusion. She has a history of allergic reactions to platelet transfusions and currently has no bleeding symptoms. The patient's mother questions the necessity of today's transfusion and asks what her daughter's risk of bleeding would be if the count is allowed to decrease lower before transfusing. You perform a literature search regarding the risk of bleeding with differing regimens for prophylactic platelet transfusions.
引用
收藏
页码：157 / 160
页数：4
相关论文
共 50 条
  • [31] Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopenia
    Josephson, Cassandra D.
    Granger, Suzanne
    Assmann, Susan F.
    Castillejo, Marta-Ines
    Strauss, Ronald G.
    Slichter, Sherrill J.
    Steiner, Marie E.
    Journeycake, Janna M.
    Thornburg, Courtney D.
    Bussel, James
    Grabowski, Eric F.
    Neufeld, Ellis J.
    Savage, William
    Sloan, Steven R.
    BLOOD, 2012, 120 (04) : 748 - 760
  • [32] The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia
    Rebulla, P
    Finazzi, G
    Marangoni, F
    Avvisati, G
    Gugliotta, L
    Tognoni, G
    Barbui, T
    Mandelli, F
    Sirchia, G
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (26): : 1870 - 1875
  • [33] Platelet Transfusions in Patients with Hypoproliferative Thrombocytopenia Conclusions from Clinical Trials and Current Controversies
    Crighton, Gemma L.
    Estcourt, Lise J.
    Wood, Erica M.
    Stanworth, Simon J.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 30 (03) : 541 - +
  • [34] Low-dose prophylactic platelet transfusions: time for further study, but too early for routine clinical
    Strauss, RG
    TRANSFUSION, 2004, 44 (12) : 1680 - 1682
  • [35] THE EFFECT OF PLATELET DOSE ON THE OUTCOME OF PROPHYLACTIC PLATELET TRANSFUSION
    HERMAN, JH
    KLUMPP, TR
    CHRISTMAN, RA
    RUSSO, RR
    GOLDBERG, SL
    MANGAN, KF
    TRANSFUSION, 1995, 35 (10) : S181 - S181
  • [36] Delaying Laboratory Collection Determines Timing of Prophylactic Platelet Transfusions and Stabilizes Platelet Inventory
    Lee, Christine
    McGonigle, Andrea M.
    Ward, Dawn C.
    Ziman, Alyssa
    TRANSFUSION, 2018, 58 : 247A - 248A
  • [37] Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin
    Goodnough, LT
    Kuter, DJ
    McCullough, J
    Slichter, SJ
    DiPersio, J
    Romo, J
    Peterson, R
    Smith, KJ
    Raife, T
    Tomita, D
    Armstrong, S
    BLOOD, 2001, 98 (05) : 1346 - 1351
  • [38] Triggers for prophylactic use of platelet transfusions and optimal platelet dosing in thrombocytopenic dogs and cats
    Abrams-Ogg, ACG
    VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE, 2003, 33 (06) : 1401 - +
  • [39] CLINICAL EXPERIENCES OF FROZEN PLATELET TRANSFUSIONS
    SUMIDA, S
    CRYOBIOLOGY, 1972, 9 (04) : 328 - &
  • [40] PLATELET AND GRANULOCYTE TRANSFUSIONS IN CLINICAL MEDICINE
    GMUR, J
    THERAPEUTISCHE UMSCHAU, 1982, 39 (07) : 515 - 518
12345